Author:
Karunathilake Charani,Alles Narmadha,Dewasurendra Rajika,Weerasinghe Isurika,Chandrasiri Nipuni,Piyasiri Sachee Bhanu,Samaranayake Nilakshi,Silva Hermali,Manamperi Nuwani,Karunaweera Nadira
Funder
National Institute of Allergy and Infectious Diseases of the National Institute of Health, USA
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Insect Science,General Veterinary,General Medicine,Parasitology
Reference40 articles.
1. Athukorale DN, Seneviratne JKK, Ihalamulla RL, Premaratne UN (1992) Locally acquired cutaneous leishmaniasis in Sri Lanka. J Trop Med Hyg 95(6):432–433
2. Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S (2005) Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol 174(11):7160–7171. https://doi.org/10.4049/JIMMUNOL.174.11.7160
3. Carrillo E, Moreno J (2019) Editorial: Biomarkers in leishmaniasis. Front Cell Infect Microbiol 9(November):1–4. https://doi.org/10.3389/fcimb.2019.00388
4. Castellani A (1904) “Leishmania Donovani” in Ceylon. Seventy-Second Annual Meeting of the British Medical Association, BMJ2 629–78. https://doi.org/10.1136/bmj.2.2281.629
5. CDC (2020) Leishmaniasis. https://www.cdc.gov/parasites/leishmaniasis/index.html. Accessed 21 February 2023